Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subash Babu

Showing results (141-150 of 295) with videos related to

Pageof 30
Sort By:
The Journal of Infectious Diseases|May 30, 2013
Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitusNathella Pavan Kumar, Rathinam Sridhar, Vaithilingam V Banurekha, et al.
Plos One|November 15, 2018
Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitisGokul Raj Kathamuthu, Kadar Moideen, Vaithilingam V Banurekha, et al.
Plos Neglected Tropical Diseases|March 4, 2020
Helminth infection modulates systemic pro-inflammatory cytokines and chemokines implicated in type 2 diabetes mellitus pathogenesisAnuradha Rajamanickam, Saravanan Munisankar, Chandrakumar Dolla, et al.
Frontiers in Immunology|October 12, 2020
Impact of Helminth Infection on Metabolic and Immune Homeostasis in Non-diabetic ObesityAnuradha Rajamanickam, Saravanan Munisankar, Kannan Thiruvengadam, et al.
Cytokine|January 16, 2016
Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokinesNathella Pavan Kumar, Dina Nair, V V Banurekha, et al.
Environmental Toxicology and Pharmacology|August 28, 2016
Zinc enhances CDKN2A<sub>,</sub> pRb1 expression and regulates functional apoptosis via upregulation of p53 and p21 expression in human breast cancer MCF-7 cellNada Al-Saran, Pandurangan Subash-Babu, Doha M Al-Nouri, et al.
Tuberculosis (Edinburgh, Scotland)|November 21, 2016
Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatmentNathella Pavan Kumar, Kadar Moideen, Shanmugam Sivakumar, et al.
Nanomaterials (Basel, Switzerland)|January 22, 2024
Neuroprotective Effect of Solid Lipid Nanoparticles Loaded with <i>Lepidium sativum</i> (L.) Seed Bioactive Components Enhance Bioavailability and Wnt/β-Catenin/Camk-II Signaling Cascade in SH-SY5Y Neuroblastoma CellsNada Al-Saran, Pandurangan Subash-Babu, Laila Naif Al-Harbi, et al.
The Journal of Infection|October 9, 2016
Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factorsNathella Pavan Kumar, Kadar Moideen, Shanmugam Sivakumar, et al.
The Journal of Infectious Diseases|June 8, 2014
Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infectionNathella Pavan Kumar, Parakkal Jovvian George, Paul Kumaran, et al.
Pageof 30

Showing results (141-150 of 295) with videos related to

Sort By:
Pageof 30
The Journal of Infectious Diseases|May 30, 2013
Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitusNathella Pavan Kumar, Rathinam Sridhar, Vaithilingam V Banurekha, et al.
Plos One|November 15, 2018
Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitisGokul Raj Kathamuthu, Kadar Moideen, Vaithilingam V Banurekha, et al.
Plos Neglected Tropical Diseases|March 4, 2020
Helminth infection modulates systemic pro-inflammatory cytokines and chemokines implicated in type 2 diabetes mellitus pathogenesisAnuradha Rajamanickam, Saravanan Munisankar, Chandrakumar Dolla, et al.
Frontiers in Immunology|October 12, 2020
Impact of Helminth Infection on Metabolic and Immune Homeostasis in Non-diabetic ObesityAnuradha Rajamanickam, Saravanan Munisankar, Kannan Thiruvengadam, et al.
Cytokine|January 16, 2016
Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokinesNathella Pavan Kumar, Dina Nair, V V Banurekha, et al.
Environmental Toxicology and Pharmacology|August 28, 2016
Zinc enhances CDKN2A<sub>,</sub> pRb1 expression and regulates functional apoptosis via upregulation of p53 and p21 expression in human breast cancer MCF-7 cellNada Al-Saran, Pandurangan Subash-Babu, Doha M Al-Nouri, et al.
Tuberculosis (Edinburgh, Scotland)|November 21, 2016
Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatmentNathella Pavan Kumar, Kadar Moideen, Shanmugam Sivakumar, et al.
Nanomaterials (Basel, Switzerland)|January 22, 2024
Neuroprotective Effect of Solid Lipid Nanoparticles Loaded with <i>Lepidium sativum</i> (L.) Seed Bioactive Components Enhance Bioavailability and Wnt/β-Catenin/Camk-II Signaling Cascade in SH-SY5Y Neuroblastoma CellsNada Al-Saran, Pandurangan Subash-Babu, Laila Naif Al-Harbi, et al.
The Journal of Infection|October 9, 2016
Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factorsNathella Pavan Kumar, Kadar Moideen, Shanmugam Sivakumar, et al.
The Journal of Infectious Diseases|June 8, 2014
Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infectionNathella Pavan Kumar, Parakkal Jovvian George, Paul Kumaran, et al.
Pageof 30